SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24119353 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Alessandra Sacchi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Virology and Antimicrobial Immunity, Department of Science, Roma Tre University, 00146 Rome, Italy. Hauptthemen laut MEDLINE: COVID-19, Interferon Type I. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MIUR of Italy.
Abstract (Originalsprache)
Type I and III Interferons (IFNs) are the first lines of defense in microbial infections. They critically block early animal virus infection, replication, spread, and tropism to promote the adaptive immune response. Type I IFNs induce a systemic response that impacts nearly every cell in the host, while type III IFNs’ susceptibility is restricted to anatomic barriers and selected immune cells. Both IFN types are critical cytokines for the antiviral response against epithelium-tropic viruses being effectors of innate immunity and regulators of the development of the adaptive immune response. Indeed, the innate antiviral immune response is essential to limit virus replication at the early stages of infection, thus reducing viral spread and pathogenesis. However, many animal viruses have evolved strategies to evade the antiviral immune response. The Coronaviridae are viruses with the largest genome among the RNA viruses. Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) caused the coronavirus disease 2019 (COVID-19) pandemic. The virus has evolved numerous strategies to contrast the IFN system immunity. We intend to describe the virus-mediated evasion of the IFN responses by going through the main phases: First, the molecular mechanisms involved; second, the role of the genetic background of IFN production during SARS-CoV-2 infection; and third, the potential novel approaches to contrast viral pathogenesis by restoring endogenous type I and III IFNs production and sensitivity at the sites of infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Virology and Antimicrobial Immunity, Department of Science, Roma Tre University, 00146 Rome, Italy.
ORCID-Profile: Flavia Giannessi, Elisabetta Affabris
Förderung
- MIUR of Italy
Zitieren
APA
Sacchi, A., Giannessi, F., Sabatini, A., Percario, Z. A., & Affabris, E. (2023). SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119353
Vancouver
Sacchi A, Giannessi F, Sabatini A, Percario ZA, Affabris E. SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24119353
BibTeX
@article{Sacchi2023,
author = {Sacchi, Alessandra and Giannessi, Flavia and Sabatini, Andrea and Percario, Zulema Antonia and Affabris, Elisabetta},
title = {SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24119353}
}
EUVIMED